Cargando…

Enhanced Topoisomerase I Activity and Increased Topoisomerase IIα Content in Cisplatin‐resistant Cancer Cell Lines

Although the combined effects of cisplatin (CDDP) and DNA topoisomerase (Topo) inhibitors have been described in recent literature, little is known about the combined effects and their biological basis in CDDP‐resistant cells. The aim of the present study was to elucidate the combined effect of CDDP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Minagawa, Yukihisa, Kigawa, Junzo, Irie, Takashi, Kanamori, Yasunobu, Itamochi, Hiroaki, Cheng, Xiusi, Terakawa, Naoki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1997
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921345/ https://www.ncbi.nlm.nih.gov/pubmed/9473741 http://dx.doi.org/10.1111/j.1349-7006.1997.tb00352.x

Ejemplares similares

Cisplatin‐resistant HeLa Cells Are Resistant to Apoptosis via p53‐dependent and ‐independent Pathways
por: Minagawa, Yukihisa, et al.
Publicado: (1999)

Synergistic Enhancement of Cisplatin Cytotoxicity by SN‐38, an Active Metabolite of CPT‐11, for Cisplatin‐resistant HeLa Cells
por: Minagawa, Yukihisa, et al.
Publicado: (1994)

Sensitivity to Anticancer Agents and Resistance Mechanisms in Clear Cell Carcinoma of the Ovary
por: Itamochi, Hiroaki, et al.
Publicado: (2002)

Nedaplatin: a cisplatin derivative in cancer chemotherapy
por: Shimada, Muneaki, et al.
Publicado: (2013)

Roles of the C-terminal domains of topoisomerase IIα and topoisomerase IIβ in regulation of the decatenation checkpoint
por: Kozuki, Toshiyuki, et al.
Publicado: (2017)

Natural Products as Topoisomerase II Poisons: Effects of Thymoquinone on DNA Cleavage Mediated by Human Topoisomerase IIα
por: Ashley, Rachel E., et al.
Publicado: (2014)

Relationship between expression of topoisomerase II isoforms and intrinsic sensitivity to topoisomerase II inhibitors in breast cancer cell lines.
por: Houlbrook, S., et al.
Publicado: (1995)

Relationship between expression of topoisomerase II isoforms and intrinsic sensitivity to topoisomerase II inhibitors in breast cancer cell lines
Publicado: (1996)

Enhanced etoposide sensitivity following adenovirus-mediated human topoisomerase II α gene transfer is independent of topoisomerase II β
por: Zhou, Z, et al.
Publicado: (2001)

Topoisomerase IIα in Chromosome Instability and Personalized Cancer Therapy
por: Chen, Tao, et al.
Publicado: (2014)

Structural basis for allosteric regulation of Human Topoisomerase IIα
por: Vanden Broeck, Arnaud, et al.
Publicado: (2021)

Expanding the type IIB DNA topoisomerase family: identification of new topoisomerase and topoisomerase-like proteins in mobile genetic elements
por: Takahashi, Diane T, et al.
Publicado: (2019)

Expression of topoisomerase II alpha and beta in an adenocarcinoma cell line carrying amplified topoisomerase II alpha and retinoic acid receptor alpha genes.
por: Coutts, J., et al.
Publicado: (1993)

Correction to ‘Expanding the type IIB DNA topoisomerase family: identification of new topoisomerase and topoisomerase-like proteins in mobile genetic elements’
Publicado: (2022)

Hyperthermia, thermotolerance and topoisomerase II inhibitors.
por: Kampinga, H. H.
Publicado: (1995)

Localization of topoisomerase II in mitotic chromosomes
Publicado: (1985)

Topoisomerase II has to work late
por: Leslie, Mitch
Publicado: (2014)

Diversity and Functions of Type II Topoisomerases
por: Sutormin, D. A., et al.
Publicado: (2021)

Chromatinization Modulates Topoisomerase II Processivity
por: Lee, Jaeyoon, et al.
Publicado: (2023)

Chromatinization modulates topoisomerase II processivity
por: Lee, Jaeyoon, et al.
Publicado: (2023)

Topoisomerase gets around
por: Dove, Alan W.
Publicado: (2002)

Prognostic role of topoisomerase-IIα in advanced ovarian cancer patients
por: Ferrandina, G, et al.
Publicado: (2008)

DNA topoisomerase IIα and -β expression in human ovarian cancer
por: Withoff, S, et al.
Publicado: (1999)

Nuclear interactions of topoisomerase II α and β with phospholipid scramblase 1
por: Wyles, Jessica P., et al.
Publicado: (2007)

PIASy-dependent SUMOylation regulates DNA topoisomerase IIα activity
por: Ryu, Hyunju, et al.
Publicado: (2010)

Expression of DNA topoisomerase II-α: Clinical significance in laryngeal carcinoma
por: FENG, YAN, et al.
Publicado: (2014)

Non-Catalytic Roles of the Topoisomerase IIα C-Terminal Domain
por: Clarke, Duncan J., et al.
Publicado: (2017)

Precursor-Directed Generation of Indolocarbazoles with Topoisomerase IIα Inhibitory Activity
por: Wang, Cong, et al.
Publicado: (2018)

Topoisomerase IIα prevents ultrafine anaphase bridges by two mechanisms
por: Gemble, Simon, et al.
Publicado: (2020)

Topoisomerase IIα represses transcription by enforcing promoter-proximal pausing
por: Herrero-Ruiz, Andrés, et al.
Publicado: (2021)

Computational screening of chalcones acting against topoisomerase IIα and their cytotoxicity towards cancer cell lines
por: Sangpheak, Kanyani, et al.
Publicado: (2018)

The Structural Features of Novel Bacterial Topoisomerase Inhibitors That Define Their Activity on Topoisomerase IV
por: Kokot, Maja, et al.
Publicado: (2022)

Dynamics of human DNA topoisomerases IIα and IIβ in living cells
por: Christensen, Morten O., et al.
Publicado: (2002)

Maternal topoisomerase II alpha, not topoisomerase II beta, enables embryonic development of zebrafish top2a(-/- )mutants
por: Sapetto-Rebow, Beata, et al.
Publicado: (2011)

Bacterial topoisomerase I and topoisomerase III relax supercoiled DNA via distinct pathways
por: Terekhova, Ksenia, et al.
Publicado: (2012)

Evodiamine Stabilizes Topoisomerase I-DNA Cleavable Complex to Inhibit Topoisomerase I Activity
por: Chan, Agnes L.-F., et al.
Publicado: (2009)

Topoisomerase 3β is the major topoisomerase for mRNAs and linked to neurodevelopment and mental dysfunction
por: Ahmad, Muzammil, et al.
Publicado: (2017)

Incidence of Mutation and Deletion in Topoisomerase IIα mRNA of Etoposide and mAMSA–resistant Cell Lines
por: Matsumoto, Yoshihito, et al.
Publicado: (2001)

Differential expression of topoisomerase IIα protein in salivary gland carcinomas: histogenetic and prognostic implications
por: Maruya, Shin-ichiro, et al.
Publicado: (2009)

DNA topoisomerase IIα expression and the response toprimary chemotherapy in breast cancer
por: MacGrogan, G, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_e4urcjkgv75gc2ft5rjmjulr2f